NEWS & PRESS
WEBSTER CAPITAL ACQUIRES MEDMARK SERVICES, INC.
Waltham, MA (October 9, 2015) -- The Opiate Treatment Company, a portfolio company of Webster Capital, is pleased to announce the acquisition of MedMark Services, Inc. (the “Company” or “MedMark”), a leading opioid treatment provider (OTP) in the United States. MedMark will be combined with BAART, a Webster portfolio company that provides opioid treatment services, creating the third largest OTP in the United States.
Headquartered in Lewisville, Texas, MedMark provides comprehensive outpatient opioid treatment services to its addicted patient base through its treatment clinics in multiple states. MedMark’s services allow its patients to cope with their addictions and significantly improve the quality of their lives. The Company has performed exceptionally well, substantially expanded operations and footprint, and grown across all operational and financial metrics.
"We are excited to partner with MedMark to continue combating the growing opioid and heroin crisis in the United States," said David Malm, Co-Managing Partner and Head of Healthcare Services at Webster Capital. "The combination of MedMark and BAART will create the third largest OTP platform in the country, putting us in an excellent position to continue scaling operations across multiple states.”
About Webster Capital
Founded in 2003, Webster Capital is a private equity firm with over $600 million of committed capital which invests in the branded consumer and healthcare services industries. Webster Capital provides equity financing, expertise and a broad contact network for management buyouts and growth capital. For additional information on Webster Capital please visit www.webstercapital.com.
About MedMark Services, Inc.
Led by a seasoned management team and headquartered in Lewisville, Texas, MedMark provides comprehensive outpatient opioid treatment services to its addicted patient base through its treatment clinics in multiple states. The Company is one of the leading opioid treatment providers in the country. For additional information on MedMark, please visit www.medmark.com.